✦ LIBER ✦

Combination of Docetaxel, Epirubicin and Vinorelbine Administered Every 2 Weeks as First-line Therapy in Patients with Metastatic Breast Cancer: A Dose-finding Study

✍ Scribed by Emilio Esteban; Antonio Modollel; Luis González de Sande; Isabel Palacio; Isabel Muñiz; Yolanda Fernández; Norberto Corral; Joaquin Fra; Marian Sala; Jose María Vieitez; Enrique Estrada; AJ Lacave

Book ID: 111546808
Publisher: Springer US
Year: 2003
Tongue: English
Weight: 130 KB
Volume: 80
Category: Article
ISSN: 0167-6806
DOI: 10.1023/a:1024985309383

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Combined epirubicin and vinorelbine as f

Combined epirubicin and vinorelbine as first-line therapy in metastatic breast cancer: a pilot study performed by the Danish Breast Cancer Cooperative Group

✍ B Ejlertsen; I Højris; S Hansen; K Møholt; B Kristensen; H.T Mouridsen; J Anders 📂 Article 📅 2003 🏛 Elsevier Science 🌐 English ⚖ 144 KB

Dose-finding study of weekly docetaxel,

Dose-finding study of weekly docetaxel, epirubicin and capecitabine, as first-line treatment in advanced breast cancer

✍ S. H. Waters; A. Gillibrand; H. Berry; S. Kumar; G. Velikova; D. J. Dodwell; Tim 📂 Article 📅 2009 🏛 Springer 🌐 English ⚖ 223 KB

Phase II study of gefitinib in combinati

Phase II study of gefitinib in combination with docetaxel as first-line therapy in metastatic breast cancer

✍ Ciardiello, F; Troiani, T; Caputo, F; De Laurentiis, M; Tortora, G; Palmieri, G; 📂 Article 📅 2006 🏛 Nature Publishing Group 🌐 English ⚖ 106 KB

Randomized comparison of nab-paclitaxel

Randomized comparison of nab-paclitaxel weekly or every 3 weeks compared to docetaxel every 3 weeks as first-line therapy in patients (pts) with metastatic breast cancer (MBC)

✍ W. Gradishar; D. Krasnojon; S. Cheporov; A. Makhson; G. Manikhas; A. Clawson; P. 📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 61 KB

Phase II study of vinorelbine (alternati

Phase II study of vinorelbine (alternating intravenous and oral) in combination with docetaxel as first-line chemotherapy in metastatic breast cancer

✍ Mario Campone; Maria Blasinska-Morawiec; Anna Tekiela; Piotr Koralewski; Jean-Ch 📂 Article 📅 2008 🏛 Springer 🌐 English ⚖ 297 KB

Multicenter phase II study of trastuzuma

Multicenter phase II study of trastuzumab in combination with epirubicin and docetaxel as first-line treatment for HER2-overexpressing metastatic breast cancer

✍ M. Venturini; C. Bighin; S. Monfardini; F. Cappuzzo; N. Olmeo; A. Durando; F. Pu 📂 Article 📅 2005 🏛 Springer US 🌐 English ⚖ 218 KB